CNB Financial Leads 3 Stocks That Could Be Trading Below Estimated Fair Value

As February begins, the U.S. stock market has shown significant strength, with major indexes like the Dow Jones Industrial Average and S&P 500 posting notable gains. This positive momentum in the market presents a timely opportunity to explore stocks that might be trading below their estimated fair value. Identifying undervalued stocks requires careful analysis of both market conditions and individual company fundamentals, offering potential for investors seeking value in a robust financial landscape.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name Current Price Fair Value (Est) Discount (Est) WesBanco (WSBC) $36.65 $70.34 47.9% Q2 Holdings (QTWO) $53.23 $102.66 48.1% Northwest Bancshares (NWBI) $12.99 $25.63 49.3% Midland States Bancorp (MSBI) $22.97 $44.96 48.9% First Internet Bancorp (INBK) $21.095 $42.10 49.9% First Busey (BUSE) $26.55 $51.50 48.4% Dingdong (Cayman) (DDL) $2.89 $5.76 49.8% Coastal Financial (CCB) $83.47 $161.96 48.5% BioLife Solutions (BLFS) $22.23 $43.29 48.6% Alphatec Holdings (ATEC) $13.36 $26.12 48.9%

Click here to see the full list of 157 stocks from our Undervalued US Stocks Based On Cash Flows screener.

Let's review some notable picks from our screened stocks.

CNB Financial

Overview: CNB Financial Corporation, with a market cap of $867.31 million, operates as the bank holding company for CNB Bank, offering a range of banking products and services to individual, business, governmental, and institutional customers.

Operations: The company's revenue primarily comes from its banking segment, which generated $273.35 million.

Estimated Discount To Fair Value: 29.3%

CNB Financial is trading at a 29.3% discount to its estimated fair value based on future cash flows, highlighting its potential as an undervalued stock. The company's earnings are forecast to grow significantly at 29% annually, outpacing the US market's growth rate. Recent financial results showed strong performance with net income doubling year-over-year. However, substantial shareholder dilution and significant insider selling in the past year may warrant caution for investors.

Our comprehensive growth report raises the possibility that CNB Financial is poised for substantial financial growth. Delve into the full analysis health report here for a deeper understanding of CNB Financial.CCNE Discounted Cash Flow as at Feb 2026

Penguin Solutions

Overview: Penguin Solutions, Inc. designs, builds, deploys, and manages enterprise solutions globally with a market cap of $1.02 billion.

Operations: The company's revenue is derived from three main segments: Optimized LED ($244.26 million), Integrated Memory ($504.06 million), and Advanced Computing ($622.44 million).

Story Continues

Estimated Discount To Fair Value: 26.4%

Penguin Solutions is trading at US$19.37, below its estimated future cash flow value of US$26.31, suggesting it may be undervalued. Earnings are projected to grow significantly at 99.4% annually, surpassing the US market's average growth rate. Despite this potential, recent executive changes with Kash Shaikh as CEO bring uncertainty during the transition period. The company has also reaffirmed a modest 6% sales growth for fiscal year 2026 amidst evolving market conditions.

The growth report we've compiled suggests that Penguin Solutions' future prospects could be on the up. Unlock comprehensive insights into our analysis of Penguin Solutions stock in this financial health report.PENG Discounted Cash Flow as at Feb 2026

Privia Health Group

Overview: Privia Health Group, Inc. is a national physician-enablement company in the United States with a market cap of approximately $2.75 billion.

Operations: The company generates revenue primarily through its Healthcare Facilities & Services segment, which accounted for $2.04 billion.

Estimated Discount To Fair Value: 46%

Privia Health Group, trading at US$22.39, is valued significantly below its estimated future cash flow value of US$41.49, highlighting its potential as an undervalued stock based on cash flows. With projected earnings growth of 32.9% annually and revenue growth forecasted at 10.6%, it outpaces the broader US market's expectations. Despite a low future return on equity of 10%, analysts agree on a substantial price increase potential of 39.6%.

The analysis detailed in our Privia Health Group growth report hints at robust future financial performance. Click to explore a detailed breakdown of our findings in Privia Health Group's balance sheet health report.PRVA Discounted Cash Flow as at Feb 2026

Next Steps

Delve into our full catalog of 157 Undervalued US Stocks Based On Cash Flows here. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Interested In Other Possibilities?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include CCNEPENG and PRVA.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments